Algo version: 0.98b
PT Kimia Farma (Persero) is listed at the JKT Exchange
PT Kimia Farma (Persero) [KAEF.JK]
JKT Sector: Healthcare Industry:Medical Distribution

Is PT Kimia Farma (Persero) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, PT Kimia Farma (Persero) pays dividends. Last time was Friday 10th of June 2022 where the investors holding the stock on Monday 23rd of May 2022 were paid IDR16.32735 per share. Over the last 21 times between 2002 and 2022, PT Kimia Farma (Persero) has paid IDR147.1165 with an average of IDR7.01 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for PT Kimia Farma (Persero) 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was IDR3 030.00, you would have made a loss of IDR-2 295.00 per share or -75.74%

Yes, the average daily trading liquidity for PT Kimia Farma (Persero) is IDR2.92 million. You should therefore be able to get in and out of your positions relatively fast.

PT Kimia Farma (Persero) has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.04, the company's ability to pay off the debt is limited. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for PT Kimia Farma (Persero) to be high [0.75 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.